ClosedPublished 20 Dec 2023

Cosette Pharmaceuticals, Inc. /
Palatin Technologies, Inc.

Cosette buys Vyleesi rights from Palatin Technologies, Inc.

Buy side: Cosette Pharmaceuticals, Inc.
Buy sideCosette Pharmaceuticals, Inc.
Target: Palatin Technologies, Inc.
TargetPalatin Technologies, Inc.
Source · 20 Dec 2023
Buy side: Cosette Pharmaceuticals, Inc.
Buy sideCosette Pharmaceuticals, Inc.
Target: Palatin Technologies, Inc.
TargetPalatin Technologies, Inc.
01 / BuyerCosette Pharmaceuticals, Inc.
02 / TargetPalatin Technologies, Inc.
01

What happened

Cosette Pharmaceuticals, Inc. purchased worldwide rights to Vyleesi from Palatin Technologies, Inc. The transaction closed when the parties signed the asset purchase agreement.

Palatin will receive up to $171 million, including $12 million upfront and as much as $159 million in contingent sales-based milestone payments.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Cosette buys Vyleesi rights from Palatin Technologies, Inc.

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.